Pictor: Thomas Schlumpberger

New Zealand-based biotech firm Pictor has appointed Thomas Schlumpberger its CEO where he will be responsible for introducing the company's technology into the US and European markets. He has more than 20 years of experience in the life sciences industry and has held senior executive positions at Anixa; Invitae; Affymetrix, now part of Thermo Fisher Scientific; Inivata; and Singulex. Pictor recently received a NZ$500,000 grant from the Ministry of Business, Innovation, and Employment COVID-19 Innovation Acceleration Fund to develop a test for the detection of SARS-CoV-2 in less than an hour.